Cargando…

Change in bowel habits during menstruation: are IBD patients different?

BACKGROUND AND AIM: Many female inflammatory bowel disease (IBD) patients report symptoms exacerbation before and during menses. Our aim was to characterize their symptoms and specific risk factors in comparison with healthy controls. METHODS: Female IBD patients aged 18–50 years were asked to fill...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahat, Adi, Falach-Malik, Alona, Haj, Ola, shatz, Zina, Ben- Horin, Shomron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Noninvasive monitoring of disease activity and complications in Crohn’s disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290266/ https://www.ncbi.nlm.nih.gov/pubmed/32577133 http://dx.doi.org/10.1177/1756284820929806

Ejemplares similares

The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?
por: Yablecovitch, Doron, et al.
Publicado: (2018)

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
por: Carter, Dan, et al.
Publicado: (2018)

Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn’s disease in patients with positive results
por: Zhao, Yujie, et al.
Publicado: (2020)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease
por: Monteleone, G., et al.
Publicado: (2016)

Exposure‐response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease
por: Vande Casteele, N., et al.
Publicado: (2017)

Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy
por: Sandborn, W. J., et al.
Publicado: (2018)

A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre
por: Meade, Susanna, et al.
Publicado: (2022)

Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)

Beyond borders: Do geographic correlations suggest shared environmental factors in inflammatory bowel diseases, Hodgkin lymphoma, and multiple sclerosis
por: Fay, Shmuel, et al.
Publicado: (2023)

Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study
por: Panés, Julián, et al.
Publicado: (2019)

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease
por: Dulai, Parambir S., et al.
Publicado: (2019)

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study
por: Asscher, Vera E. R., et al.
Publicado: (2020)

Current smoking habits in British IBD patients in the age of e-cigarettes
por: Chong, Chui, et al.
Publicado: (2019)

Partners of patients with inflammatory bowel disease: how important is their support?
por: Lahat, Adi, et al.
Publicado: (2014)

Telemedicine in clinical gastroenterology practice: what do patients prefer?
por: Lahat, Adi, et al.
Publicado: (2021)

ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC
por: Waschmann, Malika, et al.
Publicado: (2022)

Association between high dietary intake of the n−3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
por: Chan, S. S. M., et al.
Publicado: (2014)

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
por: Bohm, Matthew, et al.
Publicado: (2020)

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn’s disease
por: Lansdorp, Corine A., et al.
Publicado: (2020)

Toward transmural healing: Sonographic healing is associated with improved long‐term outcomes in patients with Crohn’s disease
por: Vaughan, Rose, et al.
Publicado: (2022)

Trends in inflammatory bowel disease treatment in the past two decades‐a high‐level text mining analysis of PubMed publications
por: Klang, Eyal, et al.
Publicado: (2021)

Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD
por: Selinger, Christian Philipp, et al.
Publicado: (2021)

Case of Vicarious Menstruation
por: Porteous, J. L. H. H.
Publicado: (1878)

Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
por: Grišić, Ana‐Marija, et al.
Publicado: (2021)

Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic
por: Bonsack, Olivier, et al.
Publicado: (2023)

Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017)

Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies
por: Simsek, Melek, et al.
Publicado: (2019)

Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort
por: Lahat, Adi, et al.
Publicado: (2020)

Characterizing dual wavelength polarimetry through the eye for monitoring glucose
por: Malik, Bilal H., et al.
Publicado: (2010)

Self‐reported treatment effectiveness for Crohn's disease using a novel crowdsourcing web‐based platform
por: Engel, Tal, et al.
Publicado: (2023)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD
por: Linton, Ludvig, et al.
Publicado: (2012)

Gastric Perforation After Microwave Ablation to Adjacent Hepatocellular Lesion
por: Sharif, Kassem, et al.
Publicado: (2023)

A blood-based prognostic biomarker in IBD
por: Biasci, Daniele, et al.
Publicado: (2019)

Preclinical IBD: One more piece of the puzzle
por: Agrawal, Manasi, et al.
Publicado: (2023)

Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel
por: Avinir, Asia, et al.
Publicado: (2022)

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study
por: Sack, Stefan, et al.
Publicado: (2011)

Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification
por: De, Sourabh
Publicado: (2011)

A day in the life of a monitor!
por: Shah, Kunal
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8sof5ld49s3le83mrpg8g8615g